华熙生物控股股东拟以2亿元至3亿元增持公司股份

Core Viewpoint - Huaxi Biological (688363) announced that its controlling shareholder, Huaxi Xinyu Investment Co., Ltd., plans to increase its stake in the company, reflecting confidence in the company's future development and long-term investment value [1] Group 1 - The controlling shareholder intends to use its own or self-raised funds to increase its holdings within six months from the announcement date [1] - The planned increase in shareholding is set to be no less than 200 million yuan and no more than 300 million yuan [1]